Latest / The Jon and Marc Podcast
$966M Talc Verdict Rocks J&J as Zantac, NEC, and Depo See Major Shifts
This week’s Tort Talks covers the major rulings and developments shaping the mass tort landscape one week before MTMP:
Talcum Powder: A $966 million verdict against J&J in a California mesothelioma trial raises pressure ahead of the first ovarian cancer bellwether set to begin November 3.
Zantac: Oral arguments at the Second Circuit challenge the MDL’s expert exclusion, a decision that could revive tens of thousands of claims and signal what’s ahead for Tylenol.
NEC: A new case management conference is expected to reset the bellwether schedule after earlier dismissals, with a push for backup…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.